Pediatric Blood & Cancer · 2004 · 53 citations · 26 references
MedicineNephrologyOncologyPediatric NephrologyRenal PathologyRenal PathophysiologyRenal DiseaseRenal Function TestingRenal Function TestsRenal ImpairmentRenal NeoplasmsWilms TumorCystatin CCystatin C-based AssessmentPediatric Renal NeoplasmsRenal Cell Carcinoma BiomarkersRenal Enzyme MarkersRenal Tubular Function TestsTubular Function AssessmentUrine Protein Testing
BACKGROUND: Late nephrotoxicity among childhood cancer survivors is poorly documented. METHODS: We investigated 115 patients and 86 controls assessing serum cystatin C concentration (CysC), urinary N-acetyl-beta-D-glucosaminidase activity (NAG), and microalbuminuria. Proteinuria was quantified and electrophoresis performed. Polymorphism of the angiotensin convertase enzyme (ACE) gene was determined by genomic PCR. RESULTS: CysC was elevated in Wilms tumor (WT) patients. Gross proteinuria was observed in 30 patients including three patients with progressive proteinuria who improved on ACE-inhibitor treatment. Neither patients with proteinuria nor the entire study population differed from controls with respect to ACE polymorphism. Pathologically elevated urinary NAG was noted in 38% of leukemia/lymphoma, 54% of solid tumor, 20% of WT survivors. A similar distribution of pathological microalbuminuria was found. CONCLUSIONS: Mild-to-moderate subclinical glomerular and tubular damage can be identified in many childhood cancer survivors. However, most patients experience some spontaneous recovery from acute nephrotoxicity.
26
Alfred Reiter, Martin Schrappe, Reza Parwaresch et al. · Journal of Clinical Oncology · 1995 · 321 citations
Medicine, Hematology, Oncology +13
Ursula Creutzig, J. Ritter, M Zimmermann et al. · Journal of Clinical Oncology · 2001 · 201 citations
Medicine, Oncology, Pediatrics +17